Clinical trials: multiple sclerosis
Multiple Sclerosis
Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)
The investigation will involve a double-blind, placebo controlled, cross-over study examining the efficacy of armodafinil in improving neurocognitive functioning and reducing cognitive fatigue in MS.
- Trial name
- NCT00981084
- Testing
- armodafinil
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- University of Missouri, Kansas City
Multiple Sclerosis
Multiple Sclerosis Registry in Argentina (RelevarEM)
The main reason for RelevarEM project is the creation of a registry based on a web platform to facilitate the collection of epidemiological data of multiple sclerosis patients from multiple sources in Argentina.
- Trial name
- RelevarEM (NCT03375177)
- Testing
- Natural history of disease
- Where
- Argentina
- Volunteers
- 4,000 people
- Sponsor
- Hospital Italiano de Buenos Aires
Multiple Sclerosis, Relapsing-Remitting
Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis
This study aims to calibrate the Multiple Sclerosis Functional Composite (MSFC) for home implementation in a phase 2 trial of lisinopril in multiple sclerosis.
- Trial name
- NCT02369926
- Testing
- Multiple Sclerosis Functional Composite, Mobile Multiple Sclerosis Functional Composite
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Transparency Life Sciences
Multiple Sclerosis
Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis
In Multiple Sclerosis the multiplicity of physical and psychological dysfunctions have been shown to exhibit a number of life-altering problems such as fatigue, limb weakness, alteration of upper extremity fine motor…
- Trial name
- NCT02960984
- Testing
- Task Oriented rehabilitation and aerobic training
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis
The objective of APOLLO is therefore to identify biomarkers associated with the CNS involvement phenotype in early MS patients.
- Trial name
- APOLLO (NCT05326048)
- Testing
- cytof analysis
- Where
- France
- Volunteers
- 60 people
- Sponsor
- Rennes University Hospital
Relapsing Multiple Sclerosis
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS Secondary…
- Trial name
- GEMINI 1 (NCT04410978)
- Testing
- Tolebrutinib, Teriflunomide
- Where
- 179 sites in United States, Austria and 22 more
- Volunteers
- 974 people
- Sponsor
- Sanofi
Tuberous Sclerosis, Angiofibroma
Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
The purpose of this trial is to evaluate the efficacy and safety of NPC-12G gel (topical formulation of sirolimus) versus placebo gel to facial angiofibroma and other skin lesions in patients with tuberous sclerosis complex (TSC)
- Conditions
- Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule, Plaque
- Trial name
- NCT02635789
- Testing
- NPC-12G gel
- Where
- Japan
- Volunteers
- 62 people
- Sponsor
- Nobelpharma
Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
RTL1000 is a new agent that has not been previously tested in humans. It is thought that RTL may specifically control the abnormal immune response or attack against the insulation on the nerves that occurs in multiple sclerosis.
- Trial name
- NCT00411723
- Testing
- RTL1000 (recombinant T cell receptor ligand)
- Where
- 6 sites in United States
- Volunteers
- 34 people
- Sponsor
- Artielle ImmunoTherapeutics
Multiple Sclerosis, Depression
Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
The aim of this pre-post observational study is to explore if it is feasible to implement 1) routine mental health screening and b) an online Cognitive Behavioural Therapy (CBT) treatment for anxiety and/or depression (named…
- Conditions
- Multiple Sclerosis, Depression, Anxiety
- Trial name
- NCT06222359
- Testing
- COMPASS
- Volunteers
- 102 people
- Sponsor
- King's College London
Multiple Sclerosis
Optimising Access to Vocational Rehabilitation for People With Multiple Sclerosis
People with multiple sclerosis (MS) often leave the workforce prematurely due to MS symptoms and difficulties managing workplace relationships and performance.
- Trial name
- MS_Work_Hub (NCT06966115)
- Testing
- Multiple Sclerosis Vocational Rehabilitation (MSVR)
- Where
- United Kingdom
- Volunteers
- 60 people
- Sponsor
- University of Nottingham
Multiple Sclerosis, Relapsing-Remitting
Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
The purpose of this study is to determine if natalizumab in combination with Glatiramer Acetate (GA) is safe and effective in delaying progression of individuals diagnosed with relapsing-remitting Multiple Sclerosis (MS).
- Trial name
- NCT00097760
- Testing
- Natalizumab
- Volunteers
- 110 people
- Sponsor
- Biogen
Multiple Sclerosis
Muscle Vibration in MS to Improve Walking
The primary goal of this pilot study is to explore the feasibility of cyclic vibration (CV) of the lower extremity muscles to improve walking in individuals with gait deficits from multiple sclerosis (MS).
- Trial name
- NCT03403413
- Testing
- muscle vibration during walking
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- VA Office of Research and Development
Multiple Sclerosis, Relapsing Multiple Sclerosis
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
To assess safety and tolerability of patients converting from approved Relapsing Multiple Sclerosis (RMS) Disease Modifying Therapies (DMTs) to siponimod.
- Conditions
- Multiple Sclerosis, Relapsing Multiple Sclerosis, Advancing Multiple Sclerosis
- Trial name
- EXCHANGE (NCT03623243)
- Testing
- Siponimod
- Where
- 55 sites in United States, Puerto Rico
- Volunteers
- 185 people
- Sponsor
- Novartis Pharmaceuticals
Multiple Sclerosis
Effectiveness of Home-Based Exercise and Brain Stimulation for Reducing Fatigue in Patients With Multiple Sclerosis
This randomized, double-blind, parallel-group clinical trial aims to assess the effectiveness of a combined intervention consisting of a home-based therapeutic exercise program and transcranial direct current stimulation (tDCS)…
- Trial name
- NCT07567989
- Testing
- Home-Based Therapeutic Exercise Program, Transcranial Direct Current Stimulation
- Where
- 3 sites in Spain
- Volunteers
- 60 people
- Sponsor
- Jacobo Formigo
Tuberous Sclerosis Complex, Epilepsy
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
This phase I/II clinical trial is an open-label clinical trial design to verify safety and dosing for TAVT-18 (sirolimus) powder for oral solution in TSC infants (N=5).
- Trial name
- STOP2 (NCT04595513)
- Testing
- TAVT-18 (sirolimus)
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Multiple Sclerosis
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
Rationale: The Balance-Based Torso-Weighting (BBTW) is a patented evaluation system that uses strategic placement of small or lightweight weights on the trunk to improve balance and stability.
- Trial name
- BBTW-MS (NCT06981013)
- Testing
- balance based torso weighting
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of St. Augustine for Health Sciences
Multiple Sclerosis
A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
To evaluate the effectiveness, patient-reported outcomes (PROs) and safety of cladribine tablets in participants with relapsing forms of multiple sclerosis (RMS) including relapsing-remitting multiple sclerosis (RRMS) and active…
- Trial name
- NCT03933215
- Testing
- Cladribine
- Where
- 18 sites in United States
- Volunteers
- 100 people
- Sponsor
- EMD Serono Research & Development Institute, Inc.
Pain, Multiple Sclerosis
Pain in Neurorehabilitation Through Wearable Devices: an Exploratory Study
This exploratory interventional study aims at exploring the feasibility of using physiological signals recorded through wearable devices, together with artificial intelligence techniques, to assess pain automatically and…
- Trial name
- PAINLESS (NCT05747040)
- Testing
- monitoring
- Where
- Italy
- Volunteers
- 15 people
- Sponsor
- Azienda Usl di Bologna
Multiple Sclerosis, Cognitive Impairment
Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: Project EXACT
Cognitive impairment is highly prevalent, poorly-managed, and disabling in persons with MS and exercise training might represent a promising approach to manage this symptom of the disease.
- Trial name
- NCT03677440
- Testing
- Treadmill Walking Exercise Training, Stretching-and-Toning Exercise Training
- Where
- United States
- Volunteers
- 43 people
- Sponsor
- Kessler Foundation
Multiple Sclerosis
Pilates Versus Eccentric Exercises on Multiple Sclerosis
This study aims to determine whether Pilates-based stability or eccentric training is more effective for patients with multiple sclerosis(MS) with chronic non-specific low back pain(NSLBP).
- Trial name
- MS (NCT06524089)
- Testing
- Pilate training, eccentric training
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Cairo University